HopeStage
Back to all studies
Not Yet RecruitingNCT07373535

Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy

Medication studyAges 21+CanadaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 21 years.

Listed locations
Montreal and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: May 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
16
Sponsor
Kyle Greenway
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
Over 21 Years
Official registry ID
NCT07373535
Official title
Show the full official title

Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy

Recruitment & locations

Not yet recruiting

Montreal

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Kyle Greenway.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin 25mg.

Who can participate?

Listed age limits: from 21 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies